This company specializes in developing cell-derived products using mammalian cell technology to promote innovation and sustainability in the bio-industry. They focus on large-scale production of cultured meat and offer various cell-derived consumer products, including high-purity antler extracts and advanced cell culture reagents. Their technology aims to provide healthier, environmentally friendly biological products for the food, medical, and consumer goods sectors.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional animal agriculture contributes significantly to environmental degradation through greenhouse gas emissions and habitat destruction. The demand for meat and animal-derived products continues to rise, exacerbating these issues and raising concerns about animal welfare and resource sustainability.
Solution
Jimi Bio leverages advanced mammalian cell culture technology to produce sustainable, cell-derived alternatives to conventional animal products. The company establishes immortalized cell lines from animal sources and utilizes bioreactors for large-scale production of clean-label meat. Beyond cultivated meat, Jimi Bio also develops specialized ingredients for the health and cosmetic industries, such as deer antler cell extracts and cell culture media. This approach aims to reduce the environmental footprint of food production and provide high-quality, ethically sourced biological solutions.
Target Audience
Jimi Bio targets food manufacturers seeking sustainable meat alternatives, and the health and cosmetic industries looking for novel, high-performance bio-ingredients.
Features
- Proprietary cell line establishment and immortalization techniques for mammalian cells.
- Bioreactor-based cultivation systems for scalable production of cell-derived products.
- Development of clean-label cultivated meat products with desirable texture and taste profiles.
- Sikavira®: A deer antler cell extract with high bioactivity, purity, and absorption, suitable for health supplements and cosmetics.
- XR Series Cell Culture Reagents: A range of cell culture media and solutions developed on the JEVOS platform for enhanced efficiency and cost-effectiveness.
- APYCII®: High-end health products focused on cellular repair and anti-aging, utilizing advanced cell culture media technology.
- PCT international patent applications filed for key technologies, including Sikavira®.